These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24445696)

  • 21. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of metabolic syndrome with reflux esophagitis: a case-control study.
    Wu P; Ma L; Dai GX; Chen Y; Tong YL; Wang C; Yao LW; Jiang YX; Xu SC; Ai ZS
    Neurogastroenterol Motil; 2011 Nov; 23(11):989-94. PubMed ID: 21914043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of the metabolic syndrome in a Turkish adult population.
    Ozsahin AK; Gokcel A; Sezgin N; Akbaba M; Guvener N; Ozisik L; Karademir BM
    Diabetes Nutr Metab; 2004 Aug; 17(4):230-4. PubMed ID: 15575344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.
    Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):75-80. PubMed ID: 15212647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population.
    Tanyolaç S; Sertkaya Cikim A; Doğan Azezli A; Orhan Y
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):336-41. PubMed ID: 18849223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
    Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P
    Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome in Turkish children and adolescents.
    Agirbasli M; Cakir S; Ozme S; Ciliv G
    Metabolism; 2006 Aug; 55(8):1002-6. PubMed ID: 16839833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between acrochordons and the components of metabolic syndrome.
    Akpinar F; Dervis E
    Eur J Dermatol; 2012; 22(1):106-10. PubMed ID: 22063265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer.
    Friedenreich CM; Biel RK; Lau DC; Csizmadi I; Courneya KS; Magliocco AM; Yasui Y; Cook LS
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2384-95. PubMed ID: 21921255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
    Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
    Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.